BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8305630)

  • 1. Biotransformation and urinary excretion of 4-substituted amphetamines in pregnant mice.
    Foster BC; Litster DL; Buttar HS; Dawson B; Zamecnik J
    Biopharm Drug Dispos; 1993 Nov; 14(8):709-19. PubMed ID: 8305630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of pregnancy on the biotransformation and urinary excretion of methoxyphenamine in mice.
    Foster BC; Wilson DL; Cyr TD; Moffatt J; Buttar HS
    Biopharm Drug Dispos; 1995 Jan; 16(1):1-11. PubMed ID: 7711279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of tri-substituted methoxyamphetamines by Cunninghamella echinulata.
    Foster BC; McLeish J; Wilson DL; Whitehouse LW; Zamecnik J; Lodge BA
    Xenobiotica; 1992 Dec; 22(12):1383-94. PubMed ID: 1494884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine.
    Kitchen I; Tremblay J; André J; Dring LG; Idle JR; Smith RL; Williams RT
    Xenobiotica; 1979 Jul; 9(7):397-404. PubMed ID: 582863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of 2-, 3-, and 4-methoxy-amphetamines by Cunninghamella echinulata.
    Foster BC; Litster DL; Lodge BA
    Xenobiotica; 1991 Oct; 21(10):1337-46. PubMed ID: 1796610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The biotransformation of fenetylline].
    Rücker G; Neugebauer M; Heiden PG
    Arzneimittelforschung; 1988 Apr; 38(4):497-501. PubMed ID: 3401264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion and metabolism of orally administered mefenorex.
    Rendić S; Slavica M; Medić-Sarić M
    Eur J Drug Metab Pharmacokinet; 1994; 19(2):107-17. PubMed ID: 8001591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of metabolites following a single dermal dose of [14C]methyl parathion in pregnant rats.
    Abu-Qare AW; Abou-Donia MB
    Toxicology; 2000 Sep; 150(1-3):119-27. PubMed ID: 10996668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic O-demethylation of 3,4-dimethoxyamphetamine in vivo in dog and monkey.
    Midha KK; Bailey K; Cooper JK; Hubbard JW
    Xenobiotica; 1979 Aug; 9(8):485-90. PubMed ID: 117645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of p-methoxyamphetamine in dog and monkey. O-demethylation as a major route.
    Hubbard JW; Midha KK; Cooper JK
    Drug Metab Dispos; 1977; 5(4):329-34. PubMed ID: 19212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of several factors on urinary excretion of methamphetamine and its metabolites in rats.
    Yamada H; Oguri K; Yoshimura H
    Xenobiotica; 1986 Feb; 16(2):137-41. PubMed ID: 3962334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolites of p-hydroxyamphetamine in man, rat and guinea-pig.
    Sever PS; Dring LG; Williams RT
    Xenobiotica; 1976 Jun; 6(6):345-53. PubMed ID: 969562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-activity relationships in drug metabolism and disposition: pharmacokinetics of N-substituted amphetamines in humans.
    Testa B; Salvesen B
    J Pharm Sci; 1980 May; 69(5):497-501. PubMed ID: 7381729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion and biotransformation of cisapride in rats after oral administration.
    Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Mostmans E; Swysen E; Bracke J; Knaeps A; Heykants J
    Drug Metab Dispos; 1988; 16(3):410-9. PubMed ID: 2900733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
    Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
    Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species variation with respect to the metabolism and excretion of d-amphetamine and d,l-N-hydroxyamphetamine succinate.
    Danielson TJ; Davis BA; Boulton AA
    Can J Physiol Pharmacol; 1977 Jun; 55(3):439-43. PubMed ID: 884602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
    Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
    Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endosulfan elevates testosterone biotransformation and clearance in CD-1 mice.
    Wilson VS; LeBlanc GA
    Toxicol Appl Pharmacol; 1998 Jan; 148(1):158-68. PubMed ID: 9465275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of the novel bioreductive prodrug PR-104 in mice, rats, dogs, and humans.
    Gu Y; Atwell GJ; Wilson WR
    Drug Metab Dispos; 2010 Mar; 38(3):498-508. PubMed ID: 20019245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism, pharmacokinetics, and excretion of a nonpeptidic substance P receptor antagonist, ezlopitant, in normal healthy male volunteers: characterization of polar metabolites by chemical derivatization with dansyl chloride.
    Prakash C; O'Donnell J; Khojasteh-Bakht SC
    Drug Metab Dispos; 2007 Jul; 35(7):1071-80. PubMed ID: 17431029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.